The central role of pathology labs in breast cancer precision oncology: a call for action

Multigenic tests represent an essential tool for the selection of adjuvant therapy in estrogen-positive/HER2-negative (ER + /HER2-) early breast cancer (BC). The workflow of these tests, either if they are externalized or carried out in-house, generates a workload for the pathology laboratories, tha...

Full description

Bibliographic Details
Main Authors: Giancarlo Pruneri, Daniele Lorenzini, Mauro G. Mastropasqua, Giuseppe Perrone, Antonio Rizzo, Donatella Santini, Chiara C. Volpi, Saverio Cinieri, Alberto Zambelli, Anna Sapino, Isabella Castellano
Format: Article
Language:English
Published: Nature Portfolio 2023-01-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-023-00506-5